THE 2-MINUTE RULE FOR AZELAPRAG CLINICAL TRIALS

In December, BioAge declared a multi-12 months investigation collaboration with Novartis to discover and validate novel therapeutic targets within the intersection of growing old biology and work out, combining BioAge's longitudinal human growing older datasets with Novartis knowledge in work out biology.” BioAge continues to be assured in azelap